Mind Medicine Inc (MNMD) Stock Analysis

Mind Medicine Inc (MNMD) is a publicly traded company in the HEALTHCARE sector. It trades at $15.02. This page summarizes the public market data, fundamentals, and frequently asked questions for MNMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $15.02

Market Sentiment

Mind Medicine Inc currently has a Neutral sentiment score of 0.03.

About Mind Medicine Inc

Mind Medicine (MindMed) Inc. is a pioneering biotechnology company based in New York, specializing in psychedelic-inspired therapeutics aimed at addressing addiction and a range of mental health disorders. By integrating advanced research methodologies and innovative psychedelic compounds into its therapeutic offerings, MindMed is committed to developing evidence-based treatments that respond to the critical mental health crisis. The company's focus on rigorous clinical trials not only unders...

GNG Research Analysis

GNG Research scores Mind Medicine Inc (MNMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MNMD.

Frequently Asked Questions

Does MNMD pay dividends?

Mind Medicine Inc (MNMD) does not currently pay a regular dividend.